Biotech · Private company
Altor BioScience
Track this companyFree. Adds Altor BioScience to your Dealase workspace and tells you when its record changes.
Clinical trials130 recruiting or active
Pipeline programs19From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline19
- ALT-801Phase 2 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- ALT-801Phase 2 · Non-muscle Invasive Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- ALT-801Phase 2 · Relapsed or Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- ALT-801Phase 2 · Transitional Cell Carcinoma of BladderClinicalTrials.gov · fetched Nov 12, 2026
- CisplatinPhase 2 · Transitional Cell Carcinoma of BladderClinicalTrials.gov · fetched Nov 12, 2026
- CisplatinPhase 2 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 2 · Transitional Cell Carcinoma of BladderClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 2 · Non-muscle Invasive Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- N-803Phase 2 · Relapsed/Refractory Indolent B Cell Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- RituximabPhase 2 · Relapsed/Refractory Indolent B Cell Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- ALT-803Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ALT-803Phase 1 · Advanced Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- ALT-803Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 1 · Advanced Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- N-803Phase 1 · Relapsed or Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Nab-paclitaxelPhase 1 · Advanced Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- TNX-832Phase 1 · SepsisClinicalTrials.gov · fetched Nov 12, 2026
- BCG in Combination with N-803PharmacokineticsClinicalTrials.gov · fetched Nov 12, 2026
- N-803 alonePharmacokineticsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- CIML NK Cell in Head & Neck CancerPHASE1 · COMPLETED · started Jul 20, 2020ClinicalTrials.gov NCT04290546 · fetched Nov 12, 2026
- PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)TERMINATED · started Dec 9, 2019ClinicalTrials.gov NCT04142359 · fetched Nov 12, 2026
- QUILT-1.004: A Single Center, Open-label, Pharmacokinetic Study of Subcutaneous ALT-803PHASE1 · COMPLETED · started Dec 27, 2017ClinicalTrials.gov NCT03381586 · fetched Nov 12, 2026
- QUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-PaclitaxelPHASE1 · COMPLETED · started Jul 1, 2016ClinicalTrials.gov NCT02559674 · fetched Nov 12, 2026
- ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung CancerPHASE1_PHASE2 · COMPLETED · started Jan 8, 2016ClinicalTrials.gov NCT02523469 · fetched Nov 12, 2026
- QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With RituximabPHASE1_PHASE2 · TERMINATED · started Apr 17, 2015ClinicalTrials.gov NCT02384954 · fetched Nov 12, 2026
- QUILT-3.005: A Study of N-803 in Patients With Relapsed or Refractory Multiple MyelomaPHASE1 · TERMINATED · started Oct 6, 2014ClinicalTrials.gov NCT02099539 · fetched Nov 12, 2026
- A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started May 1, 2014ClinicalTrials.gov NCT01946789 · fetched Nov 12, 2026
- QUILT-3.020: A Study of ALT-801 in Patients With Relapsed or Refractory Multiple MyelomaPHASE1_PHASE2 · TERMINATED · started Aug 14, 2012ClinicalTrials.gov NCT01670994 · fetched Nov 12, 2026
- A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder CancerPHASE1_PHASE2 · TERMINATED · started Mar 30, 2012ClinicalTrials.gov NCT01625260 · fetched Nov 12, 2026
- A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial CancerPHASE1_PHASE2 · COMPLETED · started Sep 6, 2011ClinicalTrials.gov NCT01326871 · fetched Nov 12, 2026
- QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic MelanomaPHASE1_PHASE2 · TERMINATED · started Feb 1, 2010ClinicalTrials.gov NCT01029873 · fetched Nov 12, 2026
- Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress SyndromePHASE1 · COMPLETED · started Dec 1, 2004ClinicalTrials.gov NCT01438853 · fetched Nov 12, 2026